Skip to content

Clinical Investigation of POD F GF

Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2072200052
Enrollment
22
Registered
2020-11-13
Start date
2020-10-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Cataract Surgery

Sponsors

Maeda Naoyuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Subject with preoperative astigmatism < 1.0 D - The subject must be able to undergo second eye surgery within 30 days of the first eye surgery. - Other protocol-specified inclusion criteria may apply.

Exclusion criteria

Exclusion criteria: - Irregular corneal aberration that affects postoperative visual function as demonstrated by corneal topography; - Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.5 decimal for CDVA; - Subjects who may be expected to require ocular surgery (other than blepharo-surgery, laser surgery of fundus and YAG capsulotomy) during the study; - Previous refractive surgery; - Other protocol-defined exclusion criteria may apply.

Design outcomes

Primary

MeasureTime frame
-Best corrected distance visual acuity (5 m) at Visit 4A (Postoperative Day 120-180) -Distance corrected near visual acuity (40 cm) at Visit 4A (Postoperative Day 120-180) -Distance corrected intermediate visual acuity (80 cm) at Visit 4A (Postoperative Day 120-180)

Contacts

Public ContactTsunemitsu Senta

Beaver-Visitec International Japan

tsenta@bvimedical.com+81-3-5214-2277

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026